Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Promethazine HCl: Enhancing Macrophage Antibacterial Assays
2026-06-01
Promethazine HCl enables advanced immunology workflows by boosting macrophage antibacterial responses through ROS and autophagy induction. Explore key protocol optimizations and troubleshooting strategies that set this histaminergic signaling pathway inhibitor apart for inflammation research and neuroscience applications.
-
Okadaic acid: Protocol Guidance for PP1/PP2A Inhibition Assa
2026-06-01
Okadaic acid is a highly specific inhibitor of protein phosphatases PP1 and PP2A, essential for dissecting phosphorylation-dependent signaling and apoptosis in cellular models. It is best suited for researchers requiring precise modulation of serine/threonine phosphatase activity and should not be used where broad or off-target phosphatase inhibition is a concern.
-
Imipramine: Bridging Autophagy, Apoptosis, and Translational
2026-05-31
This thought-leadership article explores Imipramine's multifaceted role as a tricyclic antidepressant with antitumor and neuroprotective properties, dissecting its mechanistic influence on autophagy and apoptosis. Drawing from recent lipidomics and virology research, it offers translational researchers strategic guidance for leveraging Imipramine in advanced workflows, highlights protocol parameters, and contextualizes its unique position in the research landscape. The discussion escalates beyond conventional product pages, positioning Imipramine as a catalyst for integrative research in oncology, neuroscience, and immunology.
-
Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG
2026-05-30
This study reveals a mechanistic link between carcinogen-induced super-enhancer RNA and nasopharyngeal carcinoma metastasis, implicating the NPM1/c-Myc/NDRG1 pathway. The findings clarify how environmental factors promote tumor progression via epigenetic and transcriptional regulation, highlighting new potential biomarkers for prognosis.
-
Polyether Ionophore Toxicity: Mechanisms and Research Implic
2026-05-29
This review consolidates the clinical and molecular mechanisms of polyether ionophore toxicity, with a focus on the unique features of monovalent compounds such as Salinomycin. The findings clarify how ion transport dysregulation underpins both toxic effects in animals and the repurposing of ionophores for cancer research.
-
Angiotensin III: Applied Workflows for RAAS & Viral Assays
2026-05-29
Angiotensin III (human, mouse) enables high-fidelity modeling of RAAS signaling, bridging cardiovascular and emerging viral research. Its robust solubility and precise receptor targeting support reproducible, advanced assays across domains.
-
Naloxone Hydrochloride in Opioid Receptor Antagonist Researc
2026-05-28
Naloxone hydrochloride stands apart as a gold-standard opioid receptor antagonist for probing neural, behavioral, and immune models. Its high purity and validated performance from APExBIO enable reproducible workflows in opioid addiction, neurogenesis, and withdrawal research.
-
Verbascoside: PKC/NF-κB Inhibitor for Precision Osteoclastog
2026-05-28
Verbascoside delivers targeted PKC/NF-κB inhibition, empowering researchers to dissect osteoclastogenesis and inflammatory pathways with high reproducibility. This guide distills advanced experimental workflows, troubleshooting tactics, and cross-study insights to maximize the impact of Verbascoside in bone metabolism and signaling research.
-
A 83-01: Advanced Strategies for Targeting TGF-β/Smad in Fib
2026-05-27
Explore how A 83-01, a selective ALK-5 inhibitor, empowers next-generation TGF-β/Smad pathway research in fibrosis. This article delivers a deep scientific analysis, protocol guidance, and new insights from recent single-cell studies—going beyond previous resources.
-
Necrostatin-1: Applied RIP1 Kinase Inhibitor Use in Necropto
2026-05-27
Necrostatin-1 (Nec-1) elevates necroptosis assay fidelity by enabling precise RIP1 kinase inhibition in both in vitro and in vivo models. This article details actionable protocols, troubleshooting, and the translational impact of Nec-1, spotlighting its versatility across acute kidney injury and inflammation research.
-
Oteseconazole (VT-1161): Advanced Workflows for Candida Rese
2026-05-26
Oteseconazole (VT-1161) stands out as a next-generation antifungal agent, offering potent selectivity and low MICs against Candida, including fluconazole-resistant strains. This guide translates the latest bench research into practical protocols, troubleshooting insights, and comparative advantages for translational scientists.
-
3-Deazaneplanocin (DZNep): Reliable Epigenetic Modulation in
2026-05-26
This article explores how 3-Deazaneplanocin (DZNep, SKU A1905) offers robust solutions for researchers tackling cell viability, proliferation, and cytotoxicity assays, especially in cancer and stem cell research. Scenario-based guidance—grounded in quantitative evidence and best practices—clarifies protocol optimization, data interpretation, and product reliability for advanced epigenetic modulation.
-
Low-Affinity Blockade of N-Type Ca Channels by v-Agatoxin-IV
2026-05-25
Sidach and Mintz's study redefines the selectivity of the spider toxin v-agatoxin-IVA, revealing that at higher concentrations, it blocks not only P-type but also N-type neuronal calcium channels. This finding challenges established pharmacological classification and has significant implications for experimental design in neurophysiology and neuroprotection research.
-
Gallein: Unveiling G Protein βγ Inhibition for Precision Dis
2026-05-25
Explore how Gallein, a selective G protein βγ subunit inhibitor, enables advanced modulation of GPCR signaling for targeted cancer, immune, and cardiac disease research. This article uniquely integrates mechanistic insights and practical assay guidance to empower translational discoveries.
-
Dual-Action Kinase Inhibitors and p38α MAPK Dephosphorylatio
2026-05-24
This study elucidates how certain kinase inhibitors can simultaneously block p38α MAPK activity and enhance its dephosphorylation by stabilizing a phosphatase-accessible conformation. The findings provide a structural and mechanistic basis for developing more potent and specific kinase inhibitors, with direct relevance for research in inflammation, cell death, and neuroregeneration.